CD274 and neuroendocrine carcinoma: As an alternative, PD-1/PD-L1 checkpoint inhibitors, which are playing an increasingly important role in the treatment of metastatic squamous cell carcinoma of the head and neck, also appear to show some activity in a PD NEC, particularly when used in combination [18,31,32,33,34].